SHU 555C

Drug Profile

SHU 555C

Alternative Names: Ferumoxtran-10 - Bayer Schering Pharma; SH U 555 C; Supravist; Ultrasmall Superparamagnetic Ironoxide; USPIO

Latest Information Update: 13 Jul 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bayer Schering Pharma
  • Class Contrast media; Ferric compounds; Glucans; Oxides
  • Mechanism of Action Magnetic resonance imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Ischaemic heart disorders

Most Recent Events

  • 13 Jul 2010 No development reported - Preregistration for Ischaemic heart disorders diagnosis in Sweden (IV)
  • 21 Oct 2009 Regulatory discussions are ongoing with SHU 555C
  • 31 Dec 2006 Preregistration for Ischaemic heart disorders (diagnosis) in Sweden (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top